Supreme Court Rejects Limits on Drug-Injury Lawsuits

The high court's 6-3 decision essentially upended moves by the Bush administration to protect drug makers from lawsuits as long as the product was FDA-approved.

Many watchers had predicted that the court would decide the other way, Zipursky said.

"It was a surprise in two respects," he said. People had believed "that whatever the court did, it would rule narrowly and, in fact, the decision is quite broad."

More information

To learn more about the case, visit the U.S. Supreme Court.

SOURCES: Brian Wolfman, director, litigation group, Public Citizen, Washington, D.C.; Benjamin C. Zipursky, J.D., Ph.D., professor of law, Fordham Law School, New York City, and visiting professor, Harvard Law School, Boston; March 4, 2009, prepared statement, PhRMA; March 4, 2009, press conference, Diana Levine, Vermont

Page
  • 1
  • |
  • 2
Join the Discussion
You are using an outdated version of Internet Explorer. Please click here to upgrade your browser in order to comment.
blog comments powered by Disqus
 
You Might Also Like...